Compare LXFR & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LXFR | BME |
|---|---|---|
| Founded | 1898 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Trusts Except Educational Religious and Charitable |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 421.4M | 511.9M |
| IPO Year | 2002 | 2005 |
| Metric | LXFR | BME |
|---|---|---|
| Price | $16.27 | $39.75 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 119.7K | 52.8K |
| Earning Date | 04-28-2026 | 01-01-0001 |
| Dividend Yield | ★ 3.65% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.13 | N/A |
| Revenue | ★ $384,600,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.01 | N/A |
| P/E Ratio | $122.23 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $11.15 | $35.03 |
| 52 Week High | $16.03 | $42.74 |
| Indicator | LXFR | BME |
|---|---|---|
| Relative Strength Index (RSI) | 70.04 | 54.79 |
| Support Level | $14.74 | $37.71 |
| Resistance Level | N/A | $39.69 |
| Average True Range (ATR) | 0.56 | 0.50 |
| MACD | 0.01 | 0.05 |
| Stochastic Oscillator | 92.12 | 82.21 |
Luxfer Holdings PLC is a manufacturer industrial company innovating niche applications in materials engineering. It focuses on value creation by using its broad array of technical know-how and proprietary technologies to help create a safe, clean, and energy-efficient world. Luxfer's high-performance materials, components, and high-pressure gas containment devices are used in defense, first response and healthcare, transportation, and general industrial applications. It focuses on product lines related to magnesium alloys, zirconium chemicals, and carbon composites. Its segments are Elektron, Gas Cylinders, and Graphic Arts. It generates the majority of its revenue from Elektron and as well as Gas Cylinders.
Blackrock Health Sciences Trust has an investment objective to provide total return and income mainly through long-term capital appreciation. The Trust invests the majority of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives with exposure to the health sciences industry.